Switzerland: Polares Medical closes US$40m Series B funding

Clinical stage medical technology company Polares Medical has closed a US$40m round of financing led by Longitude Capital to advance the company’s clinical studies in Europe and the US. Decheng Capital, Endeavour Vision, IDO Investments, Earlybird Venture Capital, and Wellington Partners also participated. Polares Medical’s approach to mitral regurgitation (MR) involves replacing the posterior leaflet…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »